1. "1998"
Formats
  1. Journal Article (1040)
  2. Meeting Abstract (363)
  3. Book Section (93)
  4. Conference Paper (50)
  5. Book Whole (9)
Groups
  1. Sloan Kettering Institute Faculty (378)
  2. Department of Medicine (303)
  3. GSK Faculty (285)
  4. Surgery (249)
  5. Molecular Pharmacology and Chemistry Program Faculty (209)
  6. Solid Tumor Oncology Division (158)

More Groups

People
  1. Murray Brennan (38)
  2. Steven Larson (36)
  3. Joseph Bertino (34)
  4. Samuel Danishefsky (32)
  5. Yuman Fong (32)
  6. Carlos Cordon-Cardo (29)

More People

Years
  1. 1998 (1555)
Publications
  1. Blood (102)
  2. Proceedings of the American Association for Cancer Research Annual Meeting (71)
  3. Journal of Clinical Oncology (49)
  4. Psycho-Oncology. 1st ed (36)
  5. Modern Pathology (35)
  6. Cancer (31)

More Publications

Publishers
  1. Elsevier Inc. (156)
  2. American Association for Cancer Research (118)
  3. American Society of Hematology (102)
  4. Oxford University Press (93)
  5. Lippincott Williams & Wilkins (78)
  6. Nature Publishing Group (77)

More Publishers

Results (1555)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The role of IGF-1 receptor in IGF-1 influence on malignant hemopoiesis in vivo and in vitro
    Meeting Abstract

    Doubrovina, E.; Barnett, L.; Jagiello, C.; O'Reilly, R. J.
    British Journal of Haematology (1998)

    Fulltext@MSK | Save
  • Mutations in human glucose 6-phosphate dehydrogenase (G6PD) reflect the evolutionary history of the G6PD gene
    Meeting Abstract

    Notaro, R.; Afolayan, A.; Luzzatto, L.
    Blood (1998)

    Fulltext@MSK | Save
  • LRF, a POZ/Zinc finger transcriptional repressor, interacting with BCL-6
    Meeting Abstract

    Merghoub, T.; Cattoretti, G.; Davies, J. M.; Hawe, N.; Dalla Favera, R.; Zelent, A.; Pandolfi, P. P.
    Blood (1998)

    Fulltext@MSK | Save
  • Transendothelial migration of megakaryocytes in response to SDF-1 is mediated through VE-Cadherin resulting in apoptosis of megakaryocytes
    Meeting Abstract

    Hamada, T.; Liao, F.; Hicklin, D.; Witte, L.; Bohlen, P.; Dejana, E.; Zucker-Franklin, D.; Nachman, R. L.; Moore, M. A. S.; Rafii, S.
    Blood (1998)

    Fulltext@MSK | Save
  • The hybrid polar cytodifferentiation agent suberoylanilide hydroxamic acid (SAHA) is a potent inhibitor of histone deacetylase activity
    Meeting Abstract

    Richon, V. M.; Breslow, R.; Rifkind, R. A.; Marks, P. A.
    Blood (1998)

    Fulltext@MSK | Save
  • Arsenic trioxide (As(2)O(3)) exerts its anti-leukemic effect by inhibiting angiogenesis
    Meeting Abstract

    Roboz, G. J.; Naiyer, A. J.; Warrell, R. P.; Rafii, S.
    Blood (1998)

    Fulltext@MSK | Save
  • Dose-ranging study of arsenic trioxide in advanced hematologic cancers: Clinical pharmacokinetic and biological effects
    Meeting Abstract

    Soignet, S.; Wang, Z. G.; Nagy, J.; Maslak, P.; Chanel, S.; Ho, R.; Spriggs, D.; Ellison, R.; Pandolfi, P. P.; Warrell, R. P.
    Blood (1998)

    Fulltext@MSK | Save
  • Cell line AP-1060 with novel phenotypic and genotypic features established from acute promyelocytic leukemia (APL) patient clinically-resistant to all-trans retinoic-acid (RA) and arsenic trioxide (ATO)
    Meeting Abstract

    Kim, S. H.; Ding, W.; Cannizzaro, L.; Zohouri, M.; Gebhard, D.; Paietta, E.; Warrell, R. P.; Gallagher, R. E.
    Blood (1998)

    Fulltext@MSK | Save
  • Granulocyte-colony stimulating factor (G-CSF) may improve disease outcome in elderly patients with large cell lymphoma (LCL) treated with chop
    Meeting Abstract

    Donnelly, G. B.; Glassman, J.; Long, C.; Torres, P.; Straus, D. J.; O'Brien, J. P.; Zelenetz, A. D.; Moskowitz, C. H.; Portlock, C. S.
    Blood (1998)

    Fulltext@MSK | Save
  • Th use of stanford v overcomes poor prognostic features in patients with advanced stage Hodgkin's disease (HD)
    Meeting Abstract

    Moskowitz, C. H.; Yahalom, J.; Straus, D.; Portlock, C. S.; Goy, A.; O'Brien, J. P.; Zelenetz, A. D.
    Blood (1998)

    Fulltext@MSK | Save